Advertisement
Advertisement
U.S. markets open in 1 hour 47 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Velocys plc (OXFCF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0750+0.0150 (+25.00%)
At close: 10:45AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0600
Open0.0799
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0500 - 0.0799
52 Week Range0.0400 - 0.1200
Volume53,109
Avg. Volume4,465
Market Cap104.825M
Beta (5Y Monthly)1.02
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for OXFCF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • VELOCYS PLC
    OFIX: Raising target price to $14.00ORTHOFIX MEDICAL INC has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • Business Wire

    Fuse Medical, Inc. Announces Third Quarter 2022 Financial Results

    RICHARDSON, Texas, November 15, 2022--Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced for its third quarter ended September 30, 2022 and that it has filed its quarterly report on Form 10-Q for the quarter ended September 30, 2022 with the Securities and Exchange Commission ("SEC") on November 14, 2022.

  • Business Wire

    Fuse Medical, Inc. Ranked Among Top 150 Public Companies in Dallas-Fort Worth Metroplex

    RICHARDSON, Texas, August 23, 2022--Fuse Medical, Inc., (OTCPINK: FZMD), ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has been ranked number 149 on the 2022 list of Dallas-Fort Worth’s 150 largest public companies, by the Dallas Morning News.

  • Business Wire

    Fuse Medical, Inc. Announces Appointment of New CFO Lawrence S. Yellin

    RICHARDSON, Texas, April 11, 2022--Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the appointment of new Chief Financial Officer and member of the Executive Board, Lawrence ("Larry") S. Yellin. As CFO, Mr. Yellin will be responsible for all of the Company’s financial functions including accounting, audit, treasury, corporate finance, SEC reporting, and investor

Advertisement
Advertisement